Value Bridge — ARTHUR G JAMES CANCER HOSPITAL
Current $156M → Target $199M (+$43.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$155.8M
Current EBITDA
$198.8M
Target EBITDA
+$43.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$9.7M
Payer Mix Optimization
$23.4M
Cost to Collect Reduction
$7.8M
Clean Claim Improvement
$5.8M
Volume & Rate Growth
$38.9M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $156M to $199M. The highest-impact lever is Volume & Rate Growth at $15.6M probability-weighted.
IC talking point: "We see $43M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $473M in equity value creation."